REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and ...

The Good Housekeeping Institute tested the best day creams with 240 women for hydrated, plumper skin. Shop our winners now.

Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...

REYOBIQ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and Recurrent Glioblastoma (GBM) HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus ...

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determining the best dose for a cancer drug combination in clinical trials.The co ...

Virpax Pharmaceuticals (VRPX) announced positive results from a beagle dog dose range finding study. Probudur is the company’s long-acting ...

Creative Medical Technology Holdings announced that the U.S. Food and Drug Administration has cleared an expanded dose escalation for its ongoing Phase 1/2 trial of StemSpine usin ...

Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...

The following is a summary of “Improving prostate brachytherapy outcomes through MRI-Assisted dominant lesion dose painting,” published in the March 2025 issue of BMC Urology by Rahmani et al.

DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human ...

About 90 percent of the US population has gotten their two dose regimen to protect against measles, mumps and rubella, but ...

A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...